NCT00838838View on ClinicalTrials.gov

Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis

CompletedOBSERVATIONAL

Enrollment

26

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2009

Study Completion Date

May 31, 2009

Conditions

HypogonadismParaplegiaBone DensityOsteoporosis

Interventions

DRUG

Testosterone Undeconate (Nebido-R, BAY86-5037)

Male patients \> 18yrs in medical practices fulfilling all criteria for documentation.

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY